February is Age-Related Macular Degeneration Month

February 2023

Age-related macular degeneration (ARMD) affects roughly 11 million people in the US and is the leading cause of visual impairment for older individuals. ARMD affects central vision, where sharpest vision occurs, causing difficulty conducting daily tasks such as driving or reading. Its severe and rapid impact on vision requires vigilant prevention and screening practices, as well as a thorough understanding of diagnostic procedures and the optimal use of current and emerging therapies.

Our free COPE accredited CE course provides an overview of the multiple subtypes of ARMD, including dry, intermediate and wet ARMD, and geographic atrophy. It explores existing and emerging therapies for ARMD subtypes, as well as their efficacy and safety profiles. Take the Updates in the Management of Macular Degeneration course today.